JREU:F:F-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 47.32

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.13 (-0.47%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.39 (+0.78%)

USD 112.00B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 98.90B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.26 (-0.47%)

USD 92.14B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.25 (+1.39%)

USD 57.35B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.09 (-0.57%)

USD 53.27B
VUSA:F Vanguard Funds Public Limited ..

-0.65 (-0.64%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.94 (-0.92%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.21%)

USD 40.47B
0ZC:F Zscaler Inc

-2.88 (-1.64%)

USD 37.92B

ETFs Containing JREU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.37% 85% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.37% 83% B 69% C-
Trailing 12 Months  
Capital Gain 30.14% 88% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.14% 87% B+ 74% C
Trailing 5 Years  
Capital Gain 103.13% 98% N/A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.13% 98% N/A 75% C
Average Annual (5 Year Horizon)  
Capital Gain 15.57% 95% A 84% B
Dividend Return 15.57% 94% A 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.95% 37% F 69% C-
Risk Adjusted Return 104.15% 99% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.